Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients

The Egyptian Journal of Internal Medicine volume 30, pages 90–95 (2018)Cite this article

Abstract

Context

Antimicrobial resistance has decreased eradication rates for Helicobacter pylori (H. pylori) infection worldwide. Sequential therapy (ST) has been suggested as an alternative to conventional triple therapy (TT) for the first-line treatment of H. pylori.

Aim

The purpose of this study was to compare the efficacy and tolerance of levofloxacin-based ST with clarithromycin-based TT.

Materials and methods

This is a randomized open-label clinical trial carried out on 134 patients with dyspepsia selected from Outpatient Clinic of Hepatology and Gastroenterology Department, Zagazig University Hospital, from October 2015 till September 2016. All patients were H. pylori positive as evidenced by C13-urea breath test and rapid urease test. Patients were divided into two groups: group I 67 patients received levofloxacin-based ST whereas group II 67 patients received clarithromycin-based TT for 14 days. Eradication rates, drug compliance, and adverse events were compared among the two regimens.

Results

The intention-to-treat eradication rates were 71.6% for TT and 91% for ST (P=0.004). The adverse effects including nausea, vomiting, abdominal pain, and diarrhea were less in levofloxacin-based ST than clarithromycin-based TT, but there was no statistically significant difference (all P>0.05).

Conclusion

The efficacy of levofloxacin-based ST is significantly better in the treatment of H. pylori than TT, and it also shows good tolerability. Countries like Egypt seem to have a high clarithromycin resistance, and a large-scale clinical trial is needed to choose the first-line therapy for eradication of H. pylori infection.

References

  1. Hajimahmoodi M, Shams-Ardakani M, Saniee P, Siavoshi F, Mehrabani M, Hosseinzadeh H, et al. In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat Prod Res 2011; 25:1059–1066.

    Article  CAS  Google Scholar 

  2. Franceschi F, Gasbarrini A. Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol 2007; 21:325–334.

    Article  CAS  Google Scholar 

  3. Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Physician 2011; 83:547–552.

    PubMed  Google Scholar 

  4. Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 2016; 43:514–533.

    Article  CAS  Google Scholar 

  5. Maysaa E, Walaa O, Mahmoud A, Ahmed Z. Fluoroquinolone-resistant Helicobacter pylori strains isolated from one Egyptian University Hospital: molecular aspects. J Microbiol Antimicrob Agents 2016; 2:26–31.

    Google Scholar 

  6. El Dine S, Mubarak M, Salama R. Low seroprevalence of anti-CagA antibodies inspite of high seroprevalence of anti-H. pylori antibodies in Rural Egyptian Community. Res J Med Sci 2008; 3:118–123.

    Google Scholar 

  7. Salem OE, Youssri AH, Mohammad ON. The prevalence of H. pylori antibodies in asymptomatic young egyptian persons. J Egypt Public Health Assoc 1993; 68:333–352.

    CAS  PubMed  Google Scholar 

  8. Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: impact of social background and effect on growth. Public Health Nutr 2008; 11: 230–236.

    Article  Google Scholar 

  9. Bassily S, Frenck RW, Mohareb EW, Wierzba T, Savarino S, Hall E, et al. Seroprevalence of Helicobacter pylori among Egyptian newborns and their mothers: a preliminary report. Am J Trop Med Hyg 1999; 61: 37–40.

    Article  CAS  Google Scholar 

  10. Tarkhashvili N, Beriashvili R, Chakvetadze N, Moistsrapishvili M, Chokheli M, Sikharulidze M, et al. Helicobacter pylori infection in patients undergoing upper endoscopy, Republic of Georgia. Emerg Infect Dis 2009; 15: 504–505.

    Article  Google Scholar 

  11. Shokrzadeh L, Baghaei K, Yamaoka Y, Shiota S, Mirsattari D, Porhoseingholi A. Prevalence of Helicobacter pylori infection in dyspeptic patients in Iran. Gastroenterol Insights 2012; 4: 24–27.

    Article  Google Scholar 

  12. Kaore N, Nagdeo N, Thombare V. Comparative evaluation of the diagnostic tests for Helicobacter pylori and dietary influence for its acquisition in dyspeptic patients: a rural hospital based study in central India. J Clin Diagn Res 2012; 6:636–641.

    Google Scholar 

  13. Van Blankenstein M, van Vuuren AJ, Looman CW, Ouwendijk M, Kuipers EJ. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48:794–800.

    Article  Google Scholar 

  14. Karthick P, Sowmya T, Chidambaram K, Natarajan R. Prevalence of disease with epigastric pain with reference to gastric pathology. Internet J Health 2011; 12:2.

    Google Scholar 

  15. Marzio L, Cappello G, Ballone E. Evaluation of dyspeptic symptoms in patients with and without Helicobacter pylori infection and normal upper gastrointestinal endoscopy. Dig Liver Dis 2003; 35: 138–142.

    Article  CAS  Google Scholar 

  16. Diab M, El-Dine S, Aboul-Fadl L, Shemis M, Omran Z. Helicobacter pylori cag pathogenicity Island genes among dyspeptic patients with chronic gastritis. Egypt J Med Microbial 2009; 18:43–53.

    Google Scholar 

  17. Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia: Elsevier Health Sciences; 2009.

    Google Scholar 

  18. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64:1353–1367.

    Article  Google Scholar 

  19. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, et al. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter 2008; 13:352–360.

    Article  Google Scholar 

  20. Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, et al. Association between Helicobacter pylori and Barrett’s esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2014; 12:239–245.

    Article  Google Scholar 

  21. Grande M, Lisi G, De Sanctis F, Grande S, Esser A, Campanelli M, et al. Does a relationship still exist between gastroesophageal reflux and Helicobacter pylori in patients with reflux symptoms? World J Surg Oncol 2014; 12:375.

    Article  Google Scholar 

  22. Polat Z, Kadayifci A, Kantarcioglu M, Ozcan A, Emer O, Uygun A. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. Eur J Intern Med 2012; 23:165–168.

    Article  CAS  Google Scholar 

  23. Qian J, Ye F, Zhang J, Yang YM, Tu HM, Jiang Q, et al. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. Helicobacter 2012; 17:478–485.

    Article  CAS  Google Scholar 

  24. Zullo A, de Francesco V, Hassan C, Ridola L, Repici A, Bruzzese V, et al. Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review. Dig Liver Dis 2013; 45:18–22.

    Article  CAS  Google Scholar 

  25. Romano M, Cuomo A, Gravina AG, Miranda A, Iovene MR, Tiso A, et al. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010; 59:1465–1470.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Gastroenterology and Hepatology Unit, Faculty of Medicine, Zagazig University, 44519, 463, Zagazig, Egypt

    Waleed A. Ismail (MD) & Ehab F. Mostafa

Authors
  1. Waleed A. Ismail
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ehab F. Mostafa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Waleed A. Ismail.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ismail, W.A., Mostafa, E.F. A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients. Egypt J Intern Med 30, 90–95 (2018). https://doi.org/10.4103/ejim.ejim_6_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_6_18

Keywords